Biotech Values

[DewDiligence]

ITMN VRUS – How dumb is this? These companies are holding a webcast
on Sat April 25 from EASL on the INFORM-1 study, but the webcast is
scheduled at 1pm ET—the exact same time as VRTX’s EASL webcast
on the Telaprevir PROVE-3 study.

http://finance.yahoo.com/news/InterMune-and-Pharmasset-to-prnews-14975831.html

›InterMune and Pharmasset to Discuss INFORM-1 Results From EASL Conference, April 25

Monday April 20, 2009, 4:00 pm EDT

-- Conference Call and Webcast Scheduled --

BRISBANE, Calif., April 20 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that InterMune and Pharmasset, Inc. will host a live webcast of a discussion of the INFORM-1 results from the EASL conference on Saturday, April 25, 2009, at 7:00 p.m. CEST (1:00 p.m. EDT). Participating in the discussion will be Ed Gane, M.D., principal investigator in the INFORM-1 trial. Members of management from Roche, InterMune and Pharmasset will also be available to answer questions.

Dial-In and Webcast Details

A live webcast and slide presentation will be available through the Investor Relations pages of both InterMune and Pharmasset at www.intermune.com or www.pharmasset.com, respectively. Alternatively, interested parties may access the discussion and ask questions by dialing 888-799-0528 (U.S. & Canada) or 973-200-3372 (International), conference ID # 95452531. A webcast replay will be available approximately three hours after the call and will be archived at www.intermune.com and at www.pharmasset.com.

The companies recommend logging on at least 15 minutes prior to the start of the webcast to ensure adequate time for any software downloads that may be required.

The teleconference replay will be available for 10 business days following the call and can be accessed by dialing 800-642-1687 (U.S. & Canada) or 706-645-9291 (international), and entering conference ID # 95452531.‹